Scarica l'app Stockscreener
149.95
1.38%
-2.10
Ishares Biotechnology Etf Borsa (IBB) Ultime notizie
Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging - The Motley Fool
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
SciSparc And AutoMax Call Off Merger - Sahm
iShares Biotechnology ETF (NQ: - FinancialContent
The Best Biotech ETFs to Buy - Kiplinger
How to Invest in the Entire Biotechnology Industry Through One ETF? - NAI500
IBB: Biotech's Leading Players, All In One ETF (NASDAQ:IBB) - Seeking Alpha
Best Biotech ETFs to Watch Right Now - The Motley Fool
How to Invest in iShares Biotechnology ETF (IBB) - The Motley Fool
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - MSN
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
Biotech Sector May Flip to Market Leader by Year-End - MarketBeat
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz - Benzinga
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.2005 - MSN
BBH vs. IBB: How to Position for the Next Biotech Growth Cycle - AInvest
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH (NASDAQ:IBB) - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Healthcare Stocks Move In Different Directions On Key News - Finimize
Bio-Techne Stock: Analyst Estimates & Ratings - NewsBreak: Local News & Alerts
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
The Longevity Dividend: How Financial Institutions Are Pioneering the Future of Retirement and Healthspan Investing - AInvest
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Solar, biotech, and health insurance stocks are moving on Friday: here's why - TheStreet
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
ARKK Inflows Stay Hot - ETF.com
7 Best Biotech ETFs to Buy Now - US News Money
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
The Silver Dividend: Unlocking Longevity-Driven Investment Opportunities in Healthspan, AI, and Age-Friendly Infrastructure - AInvest
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
The Silver Dividend: Strategic Investments in Longevity Technologies and Age-Friendly Sectors for 2025 and Beyond - AInvest
The Longevity Dividend: Investing in the Future of Healthspan Extension - AInvest
Unlocking the Longevity Dividend: Growth Stocks for the Age of Extended Lifespans - AInvest
BIO assets in stake since beginning, accumulating XP for token launch with $205,000 FDV. - AInvest
The Silver Dividend: How Aging Populations Can Drive Economic Growth and Longevity-Linked Investment Opportunities - AInvest
The Silent Crisis: Aging Populations and the Retirement Security Imperative - AInvest
💸 Is there any unusual option activity or capital flow in tech ETFs? - AInvest
Vertex Pharmaceuticals Plunges 2.69%—Is This the Bottom for Vertex Pharmaceuticals? - AInvest
Health Care Stocks Slipped As Big Players Disappointed - Finimize
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday - 富途牛牛
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Vertex Pharmaceuticals Plunges 19.23%—What Storm is Brewing in Biotech? - AInvest
State-Level Innovation Resilience in a Federal Funding Vacuum - AInvest
The Longevity Dividend: Unlocking AgeTech's Potential in a World of Extended Healthspans - AInvest
The Longevity Dividend: Unlocking Investment Opportunities in an Aging World - AInvest
Health Care Stocks Take A Tumble Across The Board - Finimize
RSG Q3 EPS Forecast Lowered by National Bank Financial - Defense World
William Blair Issues Positive Outlook for SOFI Earnings - Defense World
Sen. Markwayne Mullin Purchases Shares of Zoetis Inc. (NYSE:ZTS) - Defense World
Aurora Innovation (NASDAQ:AUR) Shares Gap Up on Strong Earnings - Defense World
Rep. Robert Bresnahan, Jr. Buys JPMorgan Chase & Co. (NYSE:JPM) Stock - Defense World
Atb Cap Markets Has Negative Estimate for NOV Q3 Earnings - Defense World
LPL Financial (NASDAQ:LPLA) Shares Acquired Sen. Markwayne Mullin - Defense World
Royal Bank Of Canada Lowers NOV (NYSE:NOV) Price Target to $18.00 - Defense World
B. Riley Reaffirms “Buy” Rating for Booking (NASDAQ:BKNG) - Defense World
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Raised to Neutral at JPMorgan Chase & Co. - Defense World
Susquehanna Boosts Boeing (NYSE:BA) Price Target to $270.00 - Defense World
Q3 EPS Estimates for Montauk Renewables Reduced by B. Riley - Defense World
Reckitt Benckiser Group plc (LON:RKT) Insider Tamara Ingram Purchases 293 Shares of Stock - Defense World
Celestica (NYSE:CLS) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Q3 EPS Estimates for WM Raised by National Bank Financial - Defense World
1.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):